HTG MOLECULAR DIAGNOSTICS (HTGM) Stock News
NASDAQ:HTGM - Nasdaq - US40434H3021 - Common Stock - Currency: USD
HTGM Latest News, Press Relases and Analysis
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.
Why Is Coinbase (COIN) Stock Down 16% Today?
Coinbase (COIN) stock is falling on Tuesday with heavy trading following news that the SEC is suing the crypto exchange.
HTG Molecular stock tanks in wake of bankruptcy filing (NASDAQ:HTGM)
Shares of HTG Molecular Diagnostics (HTGM) plunged Tuesday, the day after the life sciences company filed for Chapter 11 bankruptcy protection. Read more here.
Why Is Zura Bio (ZURA) Stock Up 9% Today?
Zura Bio (ZURA) stock is on the rise Tuesday alongside a couple of positive pieces of news from the clinical-stage biotechnology company.
Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?
HTG Molecular Diagnostics (HTGM) stock is falling on Tuesday after the company announced a Chapter 11 bankruptcy filing.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the latest pre-market stock movers as we check out all of the news moving shares on Tuesday morning!
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with a look at the biggest pre-market stock movers traders will want to keep an eye on this morning!
HTG Highlights the Advantages of Its Drug Discovery Engine
TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug...
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug...
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
TUCSON, Ariz., April 06, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!
HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event
TUCSON, Ariz., Jan. 09, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...
HTG Molecular Diagnostics expects FY22
HTG Molecular Diagnostics (HTGM) expects FY22 total revenue to be ~$6.4M, including ~$2.7M of HTG Transcriptome Panel (HTP) revenue representing 42% of the total revenue.Consensus...
HTG Announces Certain Preliminary 2022 Unaudited Financial Results
Preliminary full year 2022 unaudited revenue of $6.4 million Cash and cash equivalents of $12.2 million as of December 31, 2022 TUCSON, Ariz., Jan. 06,...